Management of trials in the development of cancer chemotherapy
Open Access
- 28 February 1978
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 37 (3) , 434-447
- https://doi.org/10.1038/bjc.1978.64
Abstract
Potential anti-cancer agents have classically undergone clinical assessment in Phase I, II and III trials. This paper examines the role of these trials and pre-clinical studies in the light of improving cancer chemotherapy. Many patients must now be treated with standard therapy before investigational drugs can be ethically used. The introduction of combined modality trials will require a very prolonged follow-up to demonstrate improved survival and recognize late onset of chronic toxicity.Keywords
This publication has 19 references indexed in Scilit:
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.1975
- Some thoughts on experimental models and their clinical correlationsPublished by Elsevier ,1973
- Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man.1972
- Comparison of survival curves, 1956 versus 1962, in children with Wilms' tumor and neuroblastoma. Report of the Subcommittee on Childhood Solid Tumors, Solid Tumor Task Force, National Cancer Institute.1970
- Successful therapy for Wilms' tumor.1969
- Chemotherapy in the treatment of leukemia and Wilms' tumor.1966
- Predicting anticancer drug effects in man from laboratory animal studiesJournal of Chronic Diseases, 1962
- Coordinated phase I studies for cooperative chemotherapy groups.1962
- THE USE OF BODY SURFACE AREA AS A CRITERION OF DRUG DOSAGE IN CANCER CHEMOTHERAPY1958